Insider Transactions in Q1 2024 at Cg Oncology, Inc. (CGON)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 29
2024
|
Hong Fang Song |
BUY
Open market or private purchase
|
Direct |
263,157
+30.0%
|
$4,999,983
$19.0 P/Share
|
|
Jan 29
2024
|
Hong Fang Song |
BUY
Conversion of derivative security
|
Indirect |
4,941,368
+50.0%
|
-
|
|
Jan 29
2024
|
Hong Fang Song |
BUY
Conversion of derivative security
|
Direct |
350,771
+50.0%
|
-
|
|
Jan 29
2024
|
Corleen M. Roche CFO |
BUY
Open market or private purchase
|
Direct |
2,000
+50.0%
|
$38,000
$19.0 P/Share
|
|
Jan 29
2024
|
Vijay Kasturi Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
1,315
+50.0%
|
$24,985
$19.0 P/Share
|
|
Jan 29
2024
|
Decheng Capital Global Life Sciences Fund Iv, L.P. |
BUY
Open market or private purchase
|
Indirect |
400,000
+50.0%
|
$7,600,000
$19.0 P/Share
|
|
Jan 29
2024
|
Decheng Capital Global Life Sciences Fund Iv, L.P. |
BUY
Conversion of derivative security
|
Direct |
3,628,198
+44.32%
|
-
|